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Maintenance of bone mass and integrity requires
a tight balance between resorption by osteoclasts
and formation by osteoblasts. Exocytosis of func-
tional proteins is a prerequisite for the activity of
both cells. In the present study, we show that synap-
totagmin VII, a calcium sensor protein that regulates
exocytosis, is associated with lysosomes in osteo-
clasts and bone matrix protein-containing vesicles
in osteoblasts. Absence of synaptotagmin VII inhibits
cathepsin K secretion and formation of the ruffled
border in osteoclasts and bone matrix protein depo-
sition in osteoblasts, without affecting the differenti-
ation of either cell. Reflecting these in vitro findings,
synaptotagmin VII-deficient mice are osteopenic
due to impaired bone resorption and formation.
Therefore, synaptotagmin VII plays an important
role in bone remodeling and homeostasis by modu-
lating secretory pathways functionally important in
osteoclasts and osteoblasts.
INTRODUCTION
The skeleton is a dynamic organ that undergoes continuous re-
newal by the physiological process of remodeling, in which bone
resorption by osteoclasts precedes formation by osteoblasts. A
tight balance between these two processes is required to main-
tain bone mass and integrity. In fact, most acquired systemic
bone diseases of man are due to aberrant remodeling. Typically,
enhanced osteoclastic bone resorption leads to a reduction of
bonemass and compromised bone strength, which predisposes
to an increased risk of fractures, as occurs in osteoporosis
(Raisz, 2005; Zaidi, 2007). Alternatively, defects in osteoclast dif-
ferentiation or function can result in an abnormal accumulation of
bone, which may be structurally compromised, as observed in
osteopetrosis and osteosclerosis (Tolar et al., 2004).
Osteoclasts are multinucleated cells formed by fusion of
mononuclear precursors of the monocyte/macrophage lineage.
Macrophage colony-stimulating factor (M-CSF) and receptor ac-
tivator of nuclear factor k B (RANK) ligand (RANKL), the two prin-
cipal osteoclastogenic cytokines, induce osteoclast precursors
to express functionally important proteins which endow the cells
with an efficient and unique machinery to resorb bone (Teitel-914 Developmental Cell 14, 914–925, June 2008 ª2008 Elsevier Incbaum and Ross, 2003). In the process of matrix degradation, at-
tachment of osteoclasts to bone induces dramatic cytoskeleton
reorganization, resulting in formation of a filamentous actin ring
or sealing zone. This structure surrounds a specialized plasma
membrane domain, the ruffled border, thus forming an isolated
resorptive microenvironment between the osteoclast and under-
lying bonematrix. The ruffled border is generated by the fusion of
secretory vesicles with the bone-apposing plasma membrane
(Baron et al., 1988). During this process, protons and lysosomal
enzymes, principally cathepsin K, are secreted vectorially into
the resorption lacuna to dissolve bone mineral and digest
organic matrix, respectively (Vaananen et al., 2000). However,
the molecules modulating the transport and fusion of secretory
vesicles with the plasma membrane have not been identified.
Osteoblasts arise from mesenchymal stem cells that can
differentiate into fibroblasts, myoblasts, osteoblasts, or adipo-
cytes. The path from multipotent stem cells to osteoblasts is
controlled by two key osteogenic transcription factors, Runx2
and osterix (Ducy et al., 2000). Mature osteoblasts synthesize
and secrete type I collagen, noncollagenous proteins, enzymes,
and growth factors, which comprise major components of the
organic matrix of bone (Harada and Rodan, 2003). This newly
deposited bone matrix (osteoid) undergoes mineralization medi-
ated by matrix vesicles, which are membrane-bound extracellu-
lar structures also secreted by osteoblasts (Anderson, 1995). In
contrast to recent insights into transcriptional regulation of oste-
oblast differentiation, the secretory pathways and their media-
tors in osteoblasts remain largely unknown.
Exocytosis is a fundamental process through which eukary-
otic cells release hydrophilic secretory products into the extra-
cellular space, or translocate specific functional proteins to the
plasma membrane (Chieregatti and Meldolesi, 2005; Verhage
and Toonen, 2007). While the two major types of exocytosis,
namely constitutive and regulated, differ in their regulatory
mechanisms, fusion of exocytotic vesicles with the plasma
membrane is the common final step in both pathways and is me-
diated by v- (vesicular) and t- (target) SNAREs (soluble N-ethyl-
maleimide-sensitive fusion protein [NSF] attachment protein
[SNAP] receptors) (Jahn and Scheller, 2006). These proteins
assemble to form a four-helix bundle juxtaposing vesicle and
target membranes. Although SNAREs are sufficient to catalyze
membrane fusion, additional proteins are required to achieve
specificity and spatio-temporal control. Among these other reg-
ulators of membrane fusion is the synaptotagmin (Syt) family of
vesicular trafficking proteins (Meldolesi and Chieregatti, 2004;
Rizo et al., 2006)..
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Synaptotagmin VII in Osteoclasts and OsteoblastsFigure 1. Syt VII/ Osteoclasts Have De-
fects in Cathepsin K Secretion and Ruffled
Border Formation
(A) Syt VII+/+ and Syt VII/ BMMs were cultured
with M-CSF and RANKL on bone slices for
5 days. F-actin and nuclei were stained with
Alexa-488 phalloidin and Hoechst 33258, respec-
tively.
(B) Cathepsin K (Cat K) was costainedwith F-actin.
The secretion of Cat K into the resorption lacunae,
which are circumscribed by actin rings, was
detected by confocal microscopy.
(C) Total and cathepsin K-containing cells in (A)
and (B) were counted. Data are presented as
mean ± SD, n = 5 in each group. ** p < 0.01 versus
WT.
(D) Osteoclasts were removed from bone slices,
and resorption pits were labeled with peroxidase-
conjugated wheat germ agglutinin.
(E) Medium CTx-I level was measured by ELISA.
Lane 1, positive control in the kit; lane 2, medium
alone control; lane 3, Syt VII+/+ cultures; lane 4,
Syt VII/. Data are presented as mean ± SD, n = 6
in each group. ** p < 0.01 versus WT.
(F) Transmission electron microscopic images.
White arrows and an enlarged insert in the upper
panel identify the convoluted ruffled border in
a Syt VII+/+ osteoclast. This membrane structure
is not observed in a Syt VII/ osteoclast (white
arrows and an enlarged insertion in the lower
panel). White rectangles show the area enlarged
in the inserts. Scale bars = 6.8 mm.Fifteen Syt isoforms have been identified in mammalian cells.
Each Syt family member is distributed distinctly and exhibits dif-
ferent calcium- and phospholipid-binding affinities. While Syt I,
II, III, V, and X are expressed predominantly in the nervous sys-
tem and neuroendocrine cells, others are ubiquitous (Chapman,
2002; Sudhof and Rizo, 1996). In vitro biochemical and in vivo
genetic studies implicate Syt I, the best characterized isoform,
as an essential calcium sensor for fast, synchronous neurotrans-
mitter release in neurons (Geppert et al., 1994). Unlike Syt I,
which is localized largely on the membrane of synaptic vesicles,
Syt VII is expressed broadly (Andrews and Chakrabarti, 2005).
This isoform regulates calcium-dependent exocytosis of lyso-
somes in fibroblasts (Martinez et al., 2000) and neurons (Arantes
and Andrews, 2006), dense-core vesicles in neuroendocrine
PC12 cells (Tsuboi and Fukuda, 2007; Wang et al., 2005), insu-
lin-containing secretory granules in pancreatic islet b cells (Gao
et al., 2000; Gauthier et al., 2008; Li et al., 2007), lytic granules/
secretory lysosomes in cytotoxic lymphocytes (Fowler et al.,
2007), and lysosomemembrane delivery to phagosomes inmac-
rophages (Czibener et al., 2006). Given that macrophages are
osteoclast precursors and osteoblasts are specialized fibro-
blasts, Syt VII is a candidate to regulate calcium-dependent
secretory activities in both cell types.DRESULTS
Syt VII Regulates Osteoclast Lysosomal Exocytosis
and Ruffled Border Formation
Like wild-type (WT) cells, Syt VII/ osteoclasts cultured on bone
slices formed characteristic actin rings (Figure 1A), suggesting
that cytoskeleton organization and the signals that activate this
process are intact. However, the number of osteoclasts secret-
ing cathepsin K into the resorption lacuna, shown by dual stain-
ing of the acidic collagenase and F-actin, was greatly reduced in
the absence of Syt VII (Figures 1B and 1C). While the resorption
pits in WT cultures were well demarcated, those in Syt VII/ os-
teoclast cultures were small and irregular (Figure 1D), reminis-
cent of those produced in the absence of the integrin avb3
(Feng et al., 2001). Consistent with these morphologic findings,
CTx-I, the type-I collagen fragments cleaved by cathepsin K dur-
ing bone resorption, was decreased in Syt VII/ culture medium
(Figure 1E). Therefore, despite their capacity to form actin rings,
SytVII/ osteoclasts have diminished bone resorptive capacity.
The ruffled membrane, the resorptive organelle of the osteo-
clast, is formed by insertion of lysosomes containing cathepsin
K into the bone-apposed plasmalemma (Zhao and Vaananen,
2006). Consistent with arrested cathepsin K secretion, ruffledevelopmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc. 915
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Synaptotagmin VII in Osteoclasts and OsteoblastsFigure 2. Syt VII Associates with Lysosomes in Osteoclasts and Translocates to the Ruffled Border
(A and B) BMMs transduced with Syt VII-GFP were cultured with M-CSF and RANKL on bone slices for 5 days. Syt VII-GFP was costained for F-actin (A) or
cathepsin K (Cat K). Cells transduced with empty vector served as staining controls.
(C and D) Cytosol of mature osteoclasts was fractionated by iodixanol ultracentrifugation. The distribution of Syt VII, lysosomal proteins, and organelle markers
was detected by western blots and the data displayed graphically.
(E) Syt VII immunoprecipitates were assessed for the presence of the lysosomal v-SNARE TI-VAMP. TCL, 5% of total cell lysates.membranes which were apparent inWT cells (white arrows in the
upper panel of Figure 1F) were absent in Syt VII/ osteoclasts
(Figure 1F, lower panel). The data above indicate that Syt VII reg-
ulates osteoclast function by modulating secretion of lysosomes
containing cathepsin K, the major matrix-degrading hydrolase
(Drake et al., 1996). Consistent with this conclusion, SytVII local-
ized in perinuclear lysosomes with LAMP2, a lysosomal mem-
brane protein, in cells cultured on plastic (Figure S1, upper
panels, see the Supplemental Data available with this article on-
line). In resorbing osteoclasts cultured on bone, Syt VII also asso-
ciatedwith LAMP2, but in this circumstancebothmoleculeswere
principally in the ruffled border (Figure S1, lower panels), which
was circumscribed by actin rings (Figure 2A, upper panels).
Moreover, Syt VII colocalized with cathepsin K (Figure 2B, upper
panels).
Next, we fractionated the cytosol of mature osteoclasts by
self-generated iodixanol density gradient ultracentrifugation.
We collected 20 fractions and determined protein distribution
by western blotting. As shown in Figure 2C, the peak of active
cathepsin K (the 27 kDa species) was located in the lysosomal
fraction (fraction 2), identified by its LAMP-2 content, whereas
the 36 kD proform of the enzyme comigratedwith the trans-Golgi
network marker syntaxin 6. Of relevance, Syt VII, Rab7, and
TI-VAMP, all lysosomal proteins, were in fraction 2, which also
had sec6 and sec8 (Figure 2D), two subunits of the exocyst,
a conserved protein complex involved in the docking of exocytic
vesicles at the plasma membrane (Boyd et al., 2004; TerBush
et al., 1996). Thus, fraction 2 is enriched in proteins that are likely916 Developmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc.to be present in osteoclast secretory vesicles. Lastly, Syt VII and
TI-VAMP, the lysosomal v-SNARE, formed a complex in osteo-
clasts (Figure 2E).
We also examined osteoclastogenesis. WT and SytVII/ os-
teoclast precursors, in the form of bone marrow macrophages
(BMMs), were cultured with RANKL and M-CSF. After 3 and
5 days, the cells were stained for TRAP activity as amarker of os-
teoclast differentiation. Expression of several osteoclast differ-
entiation genes was also detected by RT-PCR and western blots
at each stage. The total number of multinucleated TRAP+ osteo-
clasts, and levels of cathepsin K, MMP-9, b3 integrin mRNA, and
c-src and cathepsin K protein (Figure S2), were indistinguishable
inWT and Syt VII/ cells as they underwent osteoclastogenesis.
Thus, Syt VII does not regulate osteoclast differentiation.
Syt VII Regulates Bone Matrix Protein Secretion
and Nodule Formation by Osteoblasts
Osteoblasts derive from mesenchymal stem cells, as do fibro-
blasts, in which Syt VII regulates lysosome exocytosis (Martinez
et al., 2000). To determine whether Syt VII deficiency has intrinsic
effects on their differentiation and/or function, we isolated calva-
rial primary osteoblasts from newborn WT and Syt VII/ mice
and cultured them with time in differentiation medium. The num-
ber of alkaline phosphatase (ALP)-expressing cells inWT and Syt
VII/ cultures was comparable (Figures 3A and 3B,left panel),
as was expression of osteocalcin, a marker of differentiated os-
teoblasts (Figure 3B,middle panel). In contrast, nodule formation
in Syt VII null osteoblast cultures was decreased (Figure 3C).
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Synaptotagmin VII in Osteoclasts and OsteoblastsNext, we examined the secretion of type I collagen, a dominant
bone matrix protein in WT and Syt VII/ osteoblast cultures.
Type I collagen is initially synthesized as a larger precursor, pro-
collagen, with NH2- and COOH-terminal propeptides that are
released extracellularly by limited proteolysis (Prockop and Kivir-
ikko, 1995). Thus, the level of intracellular proforms of type I col-
lagen a chains in total cell lysates (Figure 3D) and extracellular
mature a chains in pepsin-digested extracts (Figure 3E) was
detected by western blots with the same anti-type I collagen
antibody. The amount of type I collagen secreted into the extra-
cellular matrix, as reflected by the ratio between pro- andmature
forms of collagen a chains, was significantly decreased in Syt
VII/ osteoblasts compared to WT cells. Collectively, these
data suggest that Syt VII regulates collagen secretion by osteo-
blasts rather than their differentiation.
Weexaminednext the localizationof Syt VII in osteoblasts,with
particular focus on its association with secreted bone matrix
Figure 3. Syt VII/ Osteoblasts Differenti-
ate Normally but Form Fewer Bone Nodules
(A) Syt VII+/+ and Syt VII/ primary calvarial oste-
oblasts were cultured with differentiation media
containing 50 mg/ml ascorbic acid and 2 mM
b-glycerophosphate for 21 days. Cells were fixed
at different days and stained for alkaline phospha-
tase (ALP).
(B) Expression of ALP and osteocalcin (OC) mRNA
was analyzed by RT-PCR. GAPDH served as
loading control.
(C) Bone nodule formation was visualized with
time by Alizarin Red staining.
(D) The intracellular pro-a chains of type I collagen
in total cell lysates were detected by western blot.
Actin served as loading control.
(E) The extracellular mature form of type I collagen
a chains in pepsin-digested extracts was detected
by western blot with the same antibody as in (D).
The density of a1 bands in (D) and (E) was quanti-
fied using NIH Image J program and expressed as
a ratio.
proteins. Thus, freshly isolated calvarial
primary osteoblasts were transduced with
a retroviral vector containing Syt VII-GFP
and selected with puromycin for 3 days.
The cells were then replated and cultured
on glass coverslips in osteoblast differen-
tiationmedium, and the distribution of Syt
VII-GFP was detected by fluorescent mi-
croscopy. Syt VII-GFP was initially local-
ized at perinuclear punctuate structures
(Figure 4A, left panel). During osteoblast
maturation, localization of these Syt VII-
GFP-positive vesicles changed from
perinuclear to nodular (Figure 4A, right
panels). These nodules also contained
osteopontin (OPN) and osteocalcin (OC)
(Figures 4B and 4C). To characterize fur-
ther the subcellular localization of Syt VII
in osteoblasts, we used the same self-
generated iodixanol density gradient ul-
tracentrifugation applied to osteoclasts to fractionate the cytosol
of mature osteoblasts. Syt VII was found in a dense fraction that
again contained sec6 and sec8, but lacked the Golgi marker,
syntaxin 6 (Figure 4D). Importantly, several bone matrix proteins
including type I collagen, osteocalcin, and osteopontin are en-
riched in the same fraction (Figure 4E). Together with the colocal-
ization and functional studies shown above in Figures 4A–4C and
Figures 3C–3D, respectively, these data establish that matrix
secretion in osteoblasts is regulated by Syt VII.
Retroviral Transduction of WT Syt VII Rescues the
Phenotypes of Syt VII/ Osteoclasts and Osteoblasts
To confirm that Syt VII regulates cell-autonomous effects in
osteoclasts and osteoblasts, we constructed a retroviral vector
expressing Syt VII. Transduction of the recombinant virus into
SytVII/ osteoclast precursors rescued osteoclastic bone re-
sorption completely, as demonstrated by cathepsin K secretionDevelopmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc. 917
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(Figure 5C). Similarly, retroviral transduction of Syt VII/ osteo-
blasts restored their capacity to generate bone nodules (Fig-
ure 5D), which is probably due to enhanced type I collagen
secretion into extracellular matrix in Syt VII but not in empty
vector transduced osteoblasts (Figures 5E and 5F).
Syt VII/ Mice Are Osteopenic due to Decreased
Bone Resorption and Bone Formation
Secretion is a key step for both osteoclastic bone resorption and
osteoblastic bone formation, indicating that Syt VII may regulate
bone remodeling in vivo. To test this hypothesis, we character-
Figure 4. Syt VII Associates with Bone
Matrix Proteins in Osteoblasts
(A) The localization of Syt VII-GFP was visualized
at different days of osteoblast differentiation
cultures under fluorescent microscopy.
(B and C) Syt VII-GFP was costained with osteo-
pontin (OPN) or osteocalcin (OC) in day 14 osteo-
blast cultures by fluorescent microscopy. Empty
vector transduced cells served as staining con-
trols. Arrows in (B) and (C) overlays indicate coloc-
alization of Syt VII with OPN and OC, respectively.
(D and E) The cytosol of day 14 cultured osteo-
blasts was fractionated by iodixanol ultracentrifu-
gation. The distribution of Syt VII, organelle
markers, and bone matrix proteins was detected
by western blot analysis.
ized the bone phenotype of Syt VII/
mice. Microcomputed tomography (mCT)
analysis of the distal femora from
2-month-old WT and Syt VII/ mice re-
vealed that the null mice had a dramatic
decrease in trabecular bone volume (Fig-
ures 6A and 6B). Consistent with this
finding, Syt VII/ mice had decreased
trabecular thickness and increased tra-
becular separation (Figures 6C and 6D).
Bone mineral density was also signifi-
cantly lower in Syt VII/ mice than in
WT mice (Figure 6E). Serum levels of
CTx-I (Figure 7A) and osteocalcin
(Figure 7B), global biomarkers of bone
resorption and bone formation, respec-
tively, were decreased in knockout ani-
mals. Overall, these data indicate that
the observed lower bone mass in Syt
VII/ mice results from decreased re-
modeling. In keeping with this hypothe-
sis, the amount of osteoid, unmineralized
bone matrix newly deposited by osteo-
blasts, was significantly decreased in
Syt VII/ mice (Figure 7C) despite nor-
mal numbers of osteoclasts and osteo-
blasts (Figures 7D and 7E). Moreover,
when compared to WT controls, the
results of double calcein labeling in
Syt VII/ mice showed an almost 3-fold
decrease in mineral apposition and total bone formation rates
(Figures 7F–7H). Additionally, the level of circulating PTH, a key
bone remodeling regulating hormone, is similar in WT and Syt VII
mutant mice (Figures 7I and 7J), indicating that there is no overt
dysfunction of the parathyroid glands or kidneys. Taken together
with previous reports that there are no histological abnormalities
in major organs such as brain, liver, heart, exocrine pancreas,
spleen, and kidneys (Chakrabarti et al., 2003), we conclude
that the skeletal phenotype observed in this study results from
cell-autonomous defects in osteoclasts and osteoblasts. Finally,
mice lacking synaptotagmin VII exhibit no abnormalities in skel-
etal patterning (data not shown), suggesting that the protein918 Developmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc.
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tant in postnatal bone remodeling, as shown by development of
osteopenia in adult animals.
DISCUSSION
The exocytosis of functional proteins is a prerequisite for osteo-
clast and osteoblast function. In the context of osteoclasts, the
cells secrete hydrochloric acid to dissolve bone salts, a process
that is mediated by a vacuolar-type proton pump and charge-
coupled chloride channel, and release the lysosomal acidic hy-
drolase cathepsin K to digest the organic matrix of bone. Recent
genetic studies in humans and rodents have unveiled several
essential components of the osteoclast resorptivemachinery, in-
cluding the a3 subunit of vacuolar type proton pumps (Frattini
et al., 2000; Li et al., 1999), ClC-7 chloride channel (Kornak
et al., 2001), OSTM1 (also called gray lethal and recently identi-
fied as the b subunit/chaperone of ClC-7) (Chalhoub et al., 2003;
Lange et al., 2006), and cathepsin K (Gelb et al., 1996; Saftig
et al., 1998). Interestingly, these pumps, channels, and hydro-
Figure 5. Retroviral Transduction of WT Syt
VII Reconstitutes the Function of Syt VII/
Osteoclasts and Osteoblasts
Syt VII/ BMMs and primary osteoblasts were
isolated and transduced with empty vector or
FLAG-tagged WT Syt VII. Transduced BMMs
were cultured with M-CSF and RANKL on bone
slices for 5 days. Osteoblasts were cultured with
differentiation media for 21 days.
(A) Costaining of cathepsin K (Cat K) and F-actin.
(B) Pit staining.
(C) Medium CTx-I assay. Data are presented as
mean ± SD, n = 6 in each group. ** p < 0.01 versus
vector pMX.
(D) Bone nodule staining. * p < 0.05 versus empty
vector cultures.
(E) The level of intracellular pro-a chains of type I
collagen in total cell lysates was detected by west-
ern blot. Actin served as loading control.
(F) Western blot of extracellular mature form of
type I collagen a chains in pepsin-digested ex-
tracts from Syt VII/ and wild-type osteoblast
cultures. The density of a1 bands in (E) and (F)
was measured using NIH Image J program and
expressed as a ratio.
lases are enriched in endocytic compart-
ments in most cell types, especially lyso-
somes (Schroder et al., 2007) and in
inactive nonresorbing osteoclasts. These
proteins translocate to the ruffled border
or are secreted into the resorption lacuna
during bone resorption (Lange et al.,
2006; Zhao and Vaananen, 2006). There-
fore, one of the mechanisms by which
they can be targeted to the ruffled border
is through regulated lysosomal exocyto-
sis (Baron et al., 1988). If this is the
case, one would expect that the mole-
cules regulating the trafficking and/or
the fusion of lysosomes with the plasma membrane are also crit-
ical for osteoclast function. Consistent with this notion, inhibition
of the expression of Rab7, a small GTPase that specifically reg-
ulates late endosomal/lysosomal vesicular trafficking, impairs
osteoclast secretion and ruffled border formation (Zhao et al.,
2001). In the current study, we identified Syt VII as a keymolecule
regulating the fusion of lysosomes with the ruffled border mem-
brane and showed that it is important for osteoclast function.
Syt VII, a ubiquitously expressed and evolutionarily conserved
member of the Syt family, was first implicated in the regulation of
lysosomal exocytosis and repair of plasmamembrane wounding
in fibroblasts (Martinez et al., 2000; Reddy et al., 2001). The func-
tion of Syt VII has recently been extended to the exocytosis of ly-
sosomes and of some nonsynaptic secretory granules in a range
of specialized cells, including neuroendocrine, chromaffin, and
pancreatic b cells, as well as cytotoxic lymphocytes and macro-
phages (Czibener et al., 2006; Fowler et al., 2007; Gao et al.,
2000; Gauthier et al., 2008; Li et al., 2007; Osborne et al.,
2007; Tsuboi and Fukuda, 2007; Wang et al., 2005). Given an es-
sential role of the lysosomal pathway for regulated secretion byDevelopmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc. 919
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lated that Syt VII regulates bone resorption. We demonstrated
in this study that genetic deletion of Syt VII inhibits but does
not ablate completely cathepsin K secretion and formation of
the ruffled border in osteoclasts. Earlier work in fibroblasts has
shown that absence of Syt VII reduces lysosomal exocytosis
by about 50% but does not completely eliminate the process
(Chakrabarti et al., 2003). This result may be because there is
functional redundancy, with other calcium sensors partially com-
pensating for the absence of Syt VII (Hammarlund et al., 2008;
Rizo and Sudhof, 1998). The identity of these calcium-binding
proteins in osteoclasts remains unclear. Next, we showed that
Syt VII is a lysosomal protein in osteoclasts, a finding similar to
that for other cell types. Syt VII colocalizes with cathepsin K
and LAMP2 on lysosomes and in a lysosome-enriched fraction
containing Rab7 and sec6/sec8, two components of the exocyst
complex mediating vesicular secretion (Boyd et al., 2004;
TerBush et al., 1996). Syt VII, cathepsin K, LAMP2, and rab7 all
translocate to the ruffled membrane in resorbing osteoclasts,
as do sec6/sec8 (H.Z. and F.P.R., unpublished data). We also
showed that Syt VII interacts with the lysosome-specific
v-SNARE TI-VAMP, as previously reported in other cell types
(Rao et al., 2004). A likely binding partner of the SytVII/TI-
VAMP complex at the plasma membrane is syntaxin 4, a plasma
membrane t-SNARE protein which recognizes Syt VII in other
cells and is at the ruffled membrane in resorbing osteoclasts
(Toyomura et al., 2003). Taken together, these data indicate
that Syt VII promotes the fusion of lysosomes containing proton
pumps, chloride channels, and acidic hydrolases with the ruffled
membrane, a step which is rate limiting in bone resorption.
At least two types of secretory activities mediate bone forma-
tion by osteoblasts. The first is deposition of bone matrix pro-
teins, and the second is the delivery of matrix vesicles into the
extracellular space to facilitate mineralization. The identity of
these two sets of osteoblastic secretory vesicles is not clear,
when compared to those of the osteoclast. In this study, we
show for the first time, to our knowledge, that Syt VII specifically
regulates secretion of bone matrix proteins such as type I colla-
gen, thereby promoting bone nodule formation by osteoblasts
without affecting their differentiation. Furthermore, Syt VII colo-
Figure 6. Syt VII/ Mice Are Osteopenic
(A) Representative 3D reconstruction of mCT
images of distal femoral metaphysis from three
different mice of each genotype.
(B) The percentage of trabecular bone volume/
tissue volume (BV/TV).
(C) Trabecular thickness (Tb.Th).
(D) Trabecular separation (Tb.Sp).
(E) Bone mineral density (BMD).
Data presented in (B)–(E) are presented as mean ±
SD, n = 5 in each group of mice. * p < 0.05 versus
WT.
calized with osteocalcin and osteopontin
at bone nodules and in a membrane frac-
tionwhich also contains these proteins as
well as type I collagen, and sec6/sec8.
These data are consistent with the recent
proteomic identification of Syt VII as a bone nodule protein. The
exact mechanism of Syt VII action in osteoblasts is not clear. It is
possible that Syt VII, as in osteoclasts, mediates the fusion of
matrix vesicles with plasma membrane through interaction with
SNARE proteins and plasma membrane phospholipids (Bhangu
et al., 2001; Prele et al., 2003). Another possibility is that osteo-
blasts use lysosomes as membrane suppliers for matrix protein
secretion. A homologous process is used to repair plasma
membrane damage via SytVII-regulated lysosome exocytosis
in fibroblasts (Martinez et al., 2000; Reddy et al., 2001), cells
that are related to osteoblasts.
A separate extracellular compartment is the matrix vesicle,
identified and characterized by several groups including Ander-
son and colleagues (Anderson, 1995; Anderson et al., 2005;
Wiesmann et al., 2005). These membrane-encapsulated struc-
tures are small (50–200 nm) and hence detectable only by
electron microscopy, but play a unique and important role in cal-
cification of newly deposited matrix of bone, cartilage, or dentin
(Garimella et al., 2004; Genge et al., 2003; Kirsch et al., 1997;
Roberts et al., 2007; Takano et al., 2000). While most data con-
cerning matrix calcification are based on studies in bone and
related tissues, new evidence shows that analogous vesicular
structures have an important role in calcification of medial
arteries (reviewed in Shao et al., 2006). Finally, a recent report
describes a proteomic approach to examine the protein compo-
sition of highly purified matrix vesicles isolated from calcifying
murine osteoblasts (Xiao et al., 2007). Of importance, a number
of proteins known tobepresent in osteoid are absent in thematrix
vesicle proteome, including type I collagen, osteopontin, and os-
teocalcin, all of whichwefindare readily detectable in our purified
osteoblast fraction containing Syt VII. Thus, we conclude that our
investigations have targeted not the matrix vesicle, but rather an
intracellular compartment involved in secretion of proteins that
comprise the major organic components of hard tissues.
Our finding that SytVII plays a similar functional role in osteo-
blasts and osteoclasts, the two cell types that regulate bone tis-
sue, highlights the importance of calcium-regulated secretion in
this system. As the multiple mammalian synaptotagmin isoforms
emerged, a critical issue became the subcellular localization of
each Syt member. Although this information is still not available920 Developmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc.
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Synaptotagmin VII in Osteoclasts and OsteoblastsFigure 7. Decreased Bone Resorption and Bone Formation in Syt
VII/ Mice
(A andB) Bone resorption and bone formation rates were quantified at sacrifice
by serum CTx-I and osteocalcin levels, respectively.
(C) Osteoclast number/bone perimeter (OC/B.Pm).
(D) Osteoblast number/bone perimeter (OB/B/Pm).
(E) Osteoid surface/bone perimeter (OS.S/B.Pm).
(F) Representative fluorescentmicrographs of calcein labeling. Data in (B) to (F)
are presented asmean ± SD, n = 5 in each group of mice. * p < 0.05 versusWT.Dfor all Syt isoforms, only Syt VII has been consistently localized
on lysosomes, and in some nonsynaptic secretory vesicles of
specialized cells (Andrews and Chakrabarti, 2005). Several other
synaptotagmin isoforms are expressed in osteoclasts and oste-
oblasts, but their levels do not change in the absence of Syt VII,
except for a modest increase in Syt VI expression in mature
osteoclasts compared to WT cells (Figure S3). Since the only
known role for Syt VI is participation in the acrosome reaction
in sperm (Michaut et al., 2001; Hutt et al., 2005) and the protein
lacks the Ca2+-dependent binding of SNAREs and phospho-
lipids (Li et al., 1995) we conclude that functional redundancy
of other synaptotagmin isoforms in lysosomal secretion in oste-
oclasts and type I collagen secretion in osteoblasts is unlikely. In
addition to the differential localization, the significantly different
Ca2+ affinities of different Syt isoforms also suggest specialized
activities. In this regard, Syt VII has a high calcium-binding affin-
ity relative to Syt I (Sugita et al., 2002), which is a key regulator of
neuronal synaptic vesicle exocytosis but is not expressed in
osteoclasts. Thus, the phenotypes we detected for osteoclast
and osteoblast function in Syt VII-deficient mice suggest that
the secretory vesicles involved in bone remodeling in these
two cell types may exocytose in response to relatively low (mM)
cytosolic calcium elevations.
Since Syt VII/ mice have the gene deleted in all tissues, we
cannot rule out the possibility that systemic secretion defects in
other organs or systems have effects on bone remodeling. How-
ever, our detailed cellular and biochemical studies in both oste-
oclasts and osteoblasts in vitro show that Syt VII/ mice have
intrinsic defects in the function of both cell types, leading to os-
teopenia caused by lower bone formation and resorption rates in
Syt VII/mice. Moreover, earlier histology examination of major
organs in Syt VII/ mice (Chakrabarti et al., 2003) revealed that
there are no abnormalities in organs such as brain, liver, heart,
exocrine pancreas, spleen and parathyroid glands, and kidneys.
Additionally, the normal circulating PTH levels in Syt VII/ mice
reported in this study and the expected age-related changes in
this parameter suggest that parathyroid gland function is normal.
Finally, since changes in parathyroid secretion often reflect
altered renal function, we deduce that the kidney is not impacted
by loss of Syt VII.
Bone formation and resorption are two arms of a tightly cou-
pled remodeling process. In postmenopausal women and ovari-
ectomized animals, estrogen deficiency results in enhanced
osteoclastogenesis and bone resorption, accompanied by in-
creased bone formation. In each bone remodeling cycle, bone
formation always lags behind resorption, prompting bone loss
in this circumstance of high bone turnover. In contrast, patients
with Type II or senile osteoporosis and SAMP6- and Runx2-
II-deficient mice have a decreased bone mass due to low
bone turnover (Silva et al., 2004; Xiao et al., 2005). Thus, Syt
VII/ mice provide an animal model reflecting low-turnover
osteoporosis.
(G and H) Mineral apposition rate (MAR) and bone formation rate (BFR) in Syt
VII/ mice calculated from the data in (G). Results are presented as mean ±
SD, n = 5 in each group of mice. * p < 0.05 versus WT.
(I and J) Systemic PTH levels of 6-week-old (I) and 4-month-old (J) wild-type
and Syt VII/ mice. Data are presented as mean ± SD, n = 4 in each group
of mice.evelopmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc. 921
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presses the function of the twomajor cell types in bone. Karsenty
and colleagues showed that in addition to its previously reported
key role in osteoclast differentiation (Takayanagi et al., 2002), the
transcription factor NFAT also modulates osteoblast prolifera-
tion and function (Winslow et al., 2006). Similarly, the Noda group
reported recently that deletion of schnurri-2 results in osteopenia
(Saita et al., 2007), by inhibiting differentiation of both osteo-
blasts and osteoclasts. More recently, disruption of AKT1, a
serine/threonine kinase downstream of PI-3 kinase in mice, has
been shown to lead to low-turnover osteopenia via decreased
differentiation and enhanced apoptosis in both osteoblasts and
osteoclasts (Kawamura et al., 2007). In contrast, we find that
the numbers of these two cell types are unaltered by absence
of Syt VII, reinforcing the view that this protein acts by modulat-
ing secretion of a keymatrix protease by osteoclasts and of bone
matrix proteins by osteoblasts. Our findings provide one of the
first molecular insights into the mechanism of regulated secre-
tion by bone cells, a process that is central to their function
and the regulation of bone mass.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Cell culture media were purchased from Sigma-Aldrich. Fetal bovine serum
was purchased from Hyclone. Hoechst 33258 and peroxidase-conjugated
wheat germ agglutinin were from Sigma-Aldrich. Alexa-488 and -546 conju-
gated phalloidins were bought from Invitrogen. Antibodies were obtained
from the following sources: mouse anti-cathepsin K and rat anti-osteopontin
monoclonal antibodies (Chemicon); rat anti-LAMP-2 monoclonal antibodies,
ABL-93 and GL2A7 (Developmental Studies Hybridoma Bank, University of
Iowa); rabbit anti-GFP polyclonal antibody (Invitrogen); mouse anti-syntaxin
6, anti-sec6, and anti-sec8 monoclonal antibodies (Stressgen); goat anti-Syt
VII (N-18) and Rab7 (C19) antibodies (Santa Cruz); rabbit polyclonal anti-
type I collagen antibodies (Calbiochem and Chemicon); mouse anti-osteocal-
cin antibody (Biomedical Technologies Inc.). Mouse anti-TI-VAMPmonoclonal
antibody was a generous gift from Dr. T Galli (Institut National de la Sante´ et de
la Recherche Medicale Avenir team, Paris, France). The fluorescein-labeled
secondary antibodies used in immunofluorescence and western blots were
purchased from Jackson ImmunoResearch Laboratories and Rockland,
respectively.
Mice
The generation of Syt VII/ mice has been reported previously (Chakrabarti
et al., 2003). The mice were backcrossed to C57BL6 for more than eight gen-
erations. All animals were housed in the animal care unit of the Washington
University School of Medicine and were maintained according to guidelines
of the Association for Assessment and Accreditation of Laboratory Animal
Care. All animal procedures were approved by the Animal Studies Committee
of the Washington University School of Medicine.
Serum CTx-I, Osteocalcin, and PTH Measurements
Blood was collected retro-orbitally under anesthesia immediately prior to
sacrifice. Serum CTx-I, a specific marker of osteoclastic bone resorption,
was measured using a RatLaps ELISA kit from Nordic Bioscience Diagnostics
A/S. Serum osteocalcin levels were measured by ELISA (Biomedical Technol-
ogies Inc.). Plasma was obtained using plasma separator tubes with lithium
heparin (Becton Dickinson), and PTH levels were measured by ELISA (Immu-
topics).
Histology and Histomorphometry
The tibiae of 2-month-old Syt VII+/+ and Syt VII/ mice were fixed with 70%
ethanol followed by plastic embedding and Goldner staining, or with 10% neu-
tral buffered formalin followed by the decalcification in 14% EDTA for 4–5922 Developmental Cell 14, 914–925, June 2008 ª2008 Elsevier Inc.days, paraffin embedding, and TRAP staining. Osteoclastic and osteoblastic
perimeters were measured and analyzed using Osteomeasure (OsteoMetrics,
Atlanta, GA) in a blinded fashion.
mCT
The trabecular volume in the distal femoral metaphysis was measured using
a Scanco mCT40 scanner (Scanco Medical AG, Basserdorf, Switzerland). A
threshold of 300 was used for evaluation of all scans. 30 slices were analyzed,
starting with the first slice in which condyles and primary spongiosa were no
longer visible.
Osteoclast Culture and Bone Resorption Assays
BMMs were prepared as described previously (Zhao et al., 2005) with slight
modification. Whole bone marrow was extracted from tibiae and femora of
6- to 8-week-old Syt VII+/+ and Syt VII/ mice and incubated in red blood
cell lysis buffer (150 mM NH4Cl, 10 mM KNCO3, 0.1 mM EDTA [pH 7.4]) for
5 min. The cells were then cultured in a10 medium (a-MEM, 10% heat-inacti-
vated fetal bovine serum, 100 IU/ml penicillin, and 100 mg/ml streptomycin)
with 1/10 vol of CMG 14-12 culture supernatant (Takeshita et al., 2000). Oste-
oclasts were generated after 5 days’ culture of BMMs with 1/100 vol of CMG
14-12 culture supernatant and 100 ng/ml of recombinant RANKL. The cells
cultured on plastic dishes were fixed with 4% paraformaldehyde/PBS, and
TRAP was stained with a commercial kit (387-A, Sigma). The staining of re-
sorption lacunae was performed as described previously. In brief, osteoclasts
were removed by wiping the surface of bone slices with a soft brush. The slices
were incubated with 20 mg/ml peroxidase-conjugated wheat germ agglutinin
for 30 min. After washing in PBS, 0.52 mg/ml 3,30-diaminobenzidine was
added onto the slices for 30min. Photographswere taken under a conventional
microscope equipped with a CCD camera (Nikon USA).
Osteoblast Culture and Bone Formation Assays
Primary osteoblasts were harvested from the calvariae of 3- to 5-day-old mice
by serial collagenase digestion and cultured for 21 days with differentiation
media containing 50 mg/ml ascorbic acid and 2mM b-glycerophosphate. Cells
were fixed in 4% paraformaldehyde/PBS, and alkaline phosphatase was
stained with a kit (85L2, Sigma-Aldrich). Bone nodules were stained with
Alizarin Red.
Intra- and Extracellular Collagen Determination
Collagen levels were determined as described previously (Bateman and
Golub, 1994). In brief, osteoblasts cultured in a 100 mm dish were harvested
in lysis buffer containing 50 mM Tris HCl (pH 7.4), 150 mM NaCl, and Halt pro-
teinase inhibitor cocktail (Pierce). The cells were disrupted by sonication and
extracted on ice for 30 min. The lysates were spun at maximum speed in a mi-
crocentrifuge for 30 min at 4C. The supernatant of the cell lysates was saved
for western blot analysis. 200 ml of 0.5M acetic acid was added to the cell pellet
and incubated overnight at 4C. After centrifugation, the acetic acid insoluble
residue was then digested with pepsin (0.1 mg/ml, Sigma) in 200 ml of 0.5 M
acetic acid at 4C for 2 days. The supernatant of the pepsin digest extract
was lyophilized and the digest residue dissolved in SDS sample buffer
followed by western blot analysis for type I collagen.
Immunofluorescence
Cells were first fixed with 4% paraformaldehyde in PBS for 20 min. Free alde-
hyde groups were quenched with 50 mMNH4Cl in PBS for 10 min, followed by
permeabilization and blocking in PBS/0.2% BSA/0.1% saponin (PBSBS) for
30 min. Specific proteins were labeled with primary and secondary antibodies
in PBSBS for 45 min. F-actin was stained with Alexa-488 phalloidin. Samples
were mounted with 90% glycerol/PBS and observed using a conventional
microscope equipped with a CCD camera (Nikon USA) or a confocal laser
scanning microscope (LSM, Zeiss) (Zhao et al., 2002).
Electron Microscopy
The tibiae of 2-month-old Syt VII+/+ and Syt VII/mice were fixedwith 5%glu-
taraldehyde in 0.16 M collidine buffer (pH 7.4) overnight and then decalcified in
5%EDTA/0.1% glutaraldehyde for 7 days. The samples were then postfixed in
2% OsO4/3% K-ferrocyanide for 2 hr, dehydrated in ethanol, and embedded
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examined using a JEOL 100SX transmission electron microscope.
Ultracentrifugation and Fractionation
Mature osteoclasts were harvested in homogenization buffer containing
10mMHEPES (pH 7.4), 250mMsucrose, 1mMEDTA plus protease inhibitors.
Cells were disrupted by 10 passages through a 25-gauge needle followed by
20 strokes in a Dounce homogenizer. Nuclei and unbroken cells were pelleted
by centrifugation at 1000 g for 10min. The postnuclear supernatant wasmixed
with 50% iodixanol working solution (diluted from OptiPrep, purchased from
Greiner Bio-one) to make a 17.5% iodixanol final concentration (Gille and
Nohl, 2000; Graham et al., 1994). The mixture was spun for 3 hr at 350,000 g
in a VTi80 rotor (Beckman). 0.2 ml fractions were collected from the bottom
of the tube. The density of each fraction was measured by a refractometer
(Fisher).
RT-PCR
Total RNA was purified from different stages of osteoclast and osteoblast cul-
tures by using the RNeasy Mini Kit (QIAGEN). cDNAs were synthesized from
1 mg of total RNA using the SuperScript First-Strand Synthesis System (Invitro-
gen) in a volume of 20 ml. The reaction mixture was adjusted to 100 ml with
dH2O for PCR analysis. 1 ml of these cDNAs was then amplified with primers
specific for b3 integrin (sense, 50-TTACCCCGTGGACATCTACTA-30; anti-
sense, 50-AGTCTTCCATCCAGGGCAATA-30), cathepsin K (sense, 50-GGAA
GAAGACTCACCAGAAGC-30; antisense, 50-GTCATATAGCCGCCTCCACAG-
30), MMP-9 (sense, 50-CCTGTGTGTTCCCGTTCATCT-30; antisense, 50-CGCT
GGAATGATCTAAGCCCA-30), ALP (sense, 50-CCCTGAAACTCCAAAAGCTC-
30; antisense, 50-TCTGGTGGCATCTCGTTATC-30), osteocalcin (sense, 50-TCT
GACAAAGCCTTCATGTCC-30; antisense, 50-AAATAGTGATACCGTAGATGC
G-30), and GAPDH (sense, 50-ACTTTGTCAAGCTCATTTCC-30; antisense, 50-T
GCAGCGAACTTTATTGATG-30). After 20–35 cycles of 94C (30 s), 60C (30 s),
and 72C (30 s), 10 ml of PCR products was separated on a 1.5% agarose gel
containing 0.5 mg/ml ethidium bromide.
Western Blot Analysis and Immunoprecipitation
Cultured cells werewashedwith ice-cold PBS and lysed in 13RIPAbuffer (Up-
state). After incubation on ice for 30min, lysateswere clarified by centrifugation
at 15,000 rpm for 15 min. Thirty to fifty micrograms of protein was subjected to
SDS-polyacrylamide gels and transferred electrophoretically onto nitrocellu-
lose membranes by a semidry system (Biorad). Filters were blocked in 0.1%
casein/PBS for 1 hr and incubated with primary antibodies at 4C overnight
followed by probing with fluorescent-labeled secondary antibodies. Proteins
were visualized using Odyssey (LI-COR Biosciences) at the appropriate
wavelength.
For immunoprecipitation, cells were washed in cold PBS and lysed on ice in
buffer (20 mM HEPES [pH 7.4], 120 mM NaCl, 5% glycerol, 1 mM DTT, 0.1%
NP-40, 2 mM CaCl2, and protease inhibitors). Lysates were passed through
a 25 G needle 10 times and incubated on ice for 30 min and then clarified by
centrifugation at 15,000 rpm for 15 min. 1 mg of protein was incubated with
5–10 mg of antibodies overnight with rotation. Protein A/G agarose was then
added and incubated with rotation for 3 hr at 4C. Immunoprecipitates were
washed four times in lysis buffer, and solubilized proteins were separated by
SDS-polyacrylamide gels.
Retroviral Production and Macrophage/Osteoblast Transduction
GFP-Syt VII was cloned into the pMX-IRES-puro retroviral vector (Takeshita
et al., 2007) and transfected transiently into Plat-E packing cells using FuGENE
6 transfection reagent (Roche). Virus was collected 48 hr after transfection.
BMMs or neonatal osteoblasts were transduced with virus for 24 hr in the pres-
ence of M-CSF and 4 mg/ml Polybrene. Cells were then selected in 4 mg/ml
puromycin for 3–5 days.
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